Reduction in Fibrosis Steatohepatitis Imaging and Biomarkers in a 52-week Resmetirom NASH Trial
(as presented at EASL 2021)


Notice: Undefined variable: podlink in /home/vpsbriom/public_html/melody/webcast/components/video.php on line 52
Click icon in video above (bottom right) for full-screen

Collaboration Center